Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions

Not yet recruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Dupilumab

This study will not administer any treatment, only observe the treatment as prescribed in real world clinical practice.